Cluster determinant 4 (CD4) is a type I transmembrane glycoprotein of 58 kDa. It consists of an extracellular domain of 370 amino acids, a short transmembrane region, and a cytoplasmic domain of 40 amino acids at the C-terminal end. We investigated the structure of the 62 C-terminal residues of CD4, comprising its transmembrane and cytoplasmic domains. The five cysteine residues of this region have been replaced with serine and histidine residues in the polypeptide CD4mut. Uniformly 15 N and 13 C labeled protein was recombinantly expressed in E. coli and purified. Functional binding activity of CD4mut to protein VpU of the human immunodeficiency virus type 1 (HIV-1) was verified. Close to complete NMR resonance assignment of the 1 H, 13 C, and 15 N spins of CD4mut was accomplished. The secondary structure of CD4mut in membrane simulating dodecylphosphocholine (DPC) micelles was characterized based on secondary chemical shift analysis, NOE-based proton-proton distances, and circular dichroism spectroscopy. A stable transmembrane helix and a short amphipathic helix in the cytoplasmic region were identified. The fractional helicity of the cytoplasmic helix appears to be stabilized in the presence of DPC micelles, although the extension of this helix is reduced in comparison to previous studies on synthetic peptides in aqueous solution. The role of the amphipathic helix and its potentially variable length is discussed with respect to the biological functions of CD4.
Introduction
For many years high resolution liquid state NMR studies on integral membrane proteins (IMP) had been hampered by the large size and prohibitively long rotational correlation times of even the smallest liposomes, which arguably present the most appropriate model system for membrane protein studies. In-stead, a variety of membrane mimicking conditions have been explored that allow solubilization of individual membrane proteins in an environment, that closely matches the physicochemical conditions provided by the amphipathic lipid molecules in a membrane while being suitable for solution NMR. These systems include organic solvents of reduced polarity, detergent micelles, and small bicelles consisting of lipid and detergent, and amphipathic polymers. Reviews on the available options for membrane protein solubilization [1, 2] and thorough evaluations of a multitude of detergents for solution NMR studies on integral membrane proteins [3, 4] have been published. Detergent micelles turned out to be a good choice in many cases, allowing collection of detailed structural information by solution NMR that was compatible with solid state NMR data on the same membrane-reconstituted proteins, if available, while preserving important biological functions of the IMP in the micelle.
Reconstitution in detergent micelles or bicelles results in particle size beyond 20 kDa even for the smallest IMPs. Application of transverse relaxation-optimized [5] pulse sequences in concert with elaborate isotope labeling of protein and detergent, and spectrometers operating at ultra-high magnetic field strength is therefore advantageous in most cases, providing reduced line width and improved signal dispersion [6, 7] .
Uniform or selective isotope labeling of IMPs is also a basic requirement for the use of traditional solution NMR protein resonance assignment strategies based on triple resonance multidimensional experiments. Affordable production of isotopelabeled material requires recombinant expression, purification, and functional reconstitution of the IMP, which often presents a demanding challenge [8] .
High resolution NMR can address structure, dynamics, and molecular interactions of IMPs at different levels. The chemical shift values of selected resonances are rather sensitive to backbone torsion angles [9] , i.e. the resonance assignment itself contains already valuable information on the location of secondary structure elements in the sequence. Proton-proton distances in the folded IMP can be derived from NOESY type experiments and employed in molecular dynamics-based structure calculation protocols [10] . Confinement of the micelle-or bicelle-embedded IMP in an asymmetric environment, e.g. a stressed polyacrylamide gel [11, 12] , allows measurement of residual dipolar couplings which provide bond vector orientation within the folded IMP and may assist the determination of the three-dimensional structure of the protein backbone [13] . Periodic patterns (dipolar waves) in the measured couplings along the amino acid sequence of the IMP report on location and topology of helices [14] . High resolution NMR measurements of relaxation times and [ 1 H]- 15 N heteronuclear NOEs on micelleincorporated polypeptides provide site specific information on dynamic properties of IMPs [15, 16] . Liquid state NMR offers a wide selection of approaches for detection, mapping, or in-depth characterization of protein-protein interactions [17, 18] , many of which can be extended to interaction analysis of micelleembedded IMPs in a straightforward manner.
The number of micelle reconstituted membrane proteins that have been studied with high resolution NMR is increasing at a rapid pace. They include IMPs with one [19] , two [10] or more membrane spanning helices [7] as well as β-barrel proteins [6] . Nevertheless, NMR characterization of IMPs still is a rather complex task, requiring expression, purification, reconstitution, and functional evaluation of the IMP as well as gathering and interpretation of NMR data.
Here we report the recombinant production and initial characterization of a cysteine substitution variant of the transmembrane and cytoplasmic domain of the human cluster determinant 4 (CD4). CD4 is a type I transmembrane glycoprotein with a molecular weight of 58 kDa and consists of an extracellular region of 370 amino acids, a short transmembrane region, and a cytoplasmic domain of 40 amino acids at the C-terminal end. The CD4 T-lymphocyte coreceptor belongs to the IgG-superfamily and participates in T-cell activation and signal transduction. Surface CD4 is expressed on T lymphocytes that recognize antigens presented on class II major histocompatibility complex (MHC II) molecules [20] . This specificity of CD4 + T-cells for MHC II-expressing targets is based on direct interaction between CD4 and MHC II [21] . CD4 associates with the T-cell receptor during T-cell activation [22] . The mechanism by which CD4 participates in T-cell activation is thought to involve transduction of intracellular signals. The interaction of the lymphocyte specific kinase (Lck), a Src-homologous tyrosine kinase, with the cytoplasmic part of CD4 is a crucial step of the T-cell signaling pathway [23] .
In addition to these functions, CD4 serves as the major receptor for human immunodeficiency virus (HIV) infection [24, 25] . The virus is internalized after binding of the viral envelope glycoprotein gp120 to the extracellular domain of CD4. This leads to infection of the respective T helper cell, and the production and release of new virions.
CD4 interacts via its cytoplasmic domain with viral proteins Nef and Vpu. Vpu induces degradation of CD4 molecules in the endoplasmatic reticulum (ER). This process requires both proteins to be inserted into the same membrane compartment. The CD4 sequence relevant for this activity is located between amino acids 402-420 [26] . In contrast, Nef acts at the cell surface to mediate the internalization and lysosomal degradation of CD4 [27, 28] . Nef dependent down-regulation of CD4 is well understood on a cellular level. It appears to involve a whole set of factors [29] [30] [31] [32] [33] [34] . From mutational analysis it is known that residues 407 to 418 in the cytoplasmic tail of CD4 are necessary and sufficient for the down-regulation of CD4 by Nef [27, 28, 35] . Especially, the dileucine motif at sequence positions 413 and 414 is required for the binding and down-modulation of CD4 by Nef [36] .
The three-dimensional structure of the complex between CD4 cytoplasmic part and Lck residues 7 to 35 was determined by NMR [37] . Structural information of CD4 complexes with HIV Nef or VpU is not available yet.
Materials and methods
E. coli XL10-Gold ultracompetent cells (Stratagene) and E. coli C43(DE3) competent cells (Avidis, Saint-Beauzire, France) were employed. The original vector pTKK19xb/ub was a generous gift of Dr. Toshiyuki Kohno (Japan). Custom synthesized DNA oligomers (primers) with codon usage optimized for E. coli were obtained from BioTeZ (Berlin, Germany). Restriction enzymes were from MBI Fermentas, PreScission protease from GE Healthcare.
Perdeuterated dodecylphosphocholine (DPC-d38), 2 H 2 O, 13 C-labeled glucose and 15 N-labeled ammonium chloride were purchased from Cambridge Isotope Laboratories. The lipid 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) was from Avanti Polar Lipids, Inc. (Alabaster, AL, USA). HPLC grade organic solvents were used. All other chemicals were graded analytical or better.
Cloning, expression, and purification of CD4mut
Plasmid pTKK19_CD4mut was designed for production of the cysteine lacking, 70 residue CD4mut polypeptide as ubiquitin fusion. It is a modification of the recently described vector pTKK19_CD4tmcyt [38] that is based on the standard vector pTKK19xb/ub [39] . Site-directed mutagenesis was done by overlap extension using the polymerase chain reaction (PCR) essentially as described by Ho et al. [40] . In the first PCR, template pTKK19_CD4tmcyt was incubated with the primers CD4_C394S/C397S-5′ and CD4_C420S/C422S/ C430H_Not_3′ to amplify a double stranded DNA fragment that includes the coding sequence of the region CD4(390-433) with the five point mutations C394S; C397S; C420S; C422S; and C430H. The second PCR utilized plasmid pTKK19_CD4tmcyt as DNA template, the purified double stranded DNA fragment provided the 3′ primer, and a 5′ primer was designed containing the DNA complement of the N-terminus of the target sequence (PreScission and Thrombin protease cleavage sites followed by the N-terminus of CD4(372-433), for details see Fig. 1 in [38] ). The PCR-amplified DNA codes for the cysteine-free CD4(372-433) mutant preceded by the two protease cleavage sites. The PCR product was treated with T4 DNA polymerase to obtain blunted 5′ ends and finally digested with Not I. The resulting DNA fragment was ligated into linearized pTKK19xb/ub plasmid (Mph1103 I digested, 3′ end blunted, 5′ end Not I restricted, and dephosphorylated) using the FastLink DNA ligation kit (Biozym, Hessisch Oldendorf, Germany). The plasmid was amplified in E. coli XL10-Gold ultracompetent cells. The DNA sequence of the obtained plasmid, referred to as pTKK19_CD4mut, was confirmed by DNA sequencing (SEQLAB, Göttingen, Germany).
E. coli C43(DE3) competent cells were transformed with plasmid pTKK19_CD4mut for expression of the fusion protein comprising an N-terminal decahistidine tag, the 76 residue fusion partner yeast ubiquitin, a 14 residue linker containing PreScission and Thrombin cleavage sites, and a 62 residue, cysteinefree variant of a CD4 fragment resembling the transmembrane and cytoplasmic domains of the CD4 receptor. Expression, purification, enzymatic cleavage, and final isolation of the 70 residue CD4mut target protein ( Fig. 1 ) largely followed the recently published protocol for recombinant production of the corresponding wild type CD4tmcyt fragment [38] . Briefly, the fusion protein was expressed at high yield, is insoluble under native conditions, and was sequestered in inclusion bodies. The fusion can be solubilized by sonification in buffer containing the detergents Triton X-100 (0.5%, v/v) and cholic acid (0.5%, w/v) and is easily purified in a one-step procedure using Nickel-NTA affinity chromatography. The 70 residue CD4mut is released by enzymatic cleavage with PreScission protease in the presence of detergent, TCA-precipitated and purified to homogeneity using reversed phase chromatography.
Uniformly 15 N and 13 C isotope-labeled CD4mut for NMR studies was produced following the same protocol but growing bacteria in M9 minimal medium [41] containing 15 N-labeled ammonium chloride and/or 13 C-labeled glucose as the sole nitrogen and carbon sources, respectively.
Expression and purification of VpUcyt
VpUcyt is a soluble polypeptide corresponding to the C-terminal amino acids 39 to 81 of the accessory membrane protein VpU of HIV-1 (isolate SF162, group M, subtype B, SwissProt entry VPU_HV1S1) preceded by a GS dipeptide. VpUcyt was recombinantly produced with an N-terminal GST affinity tag using a pGEX-2T vector construct (GE Healthcare), enzymatically cleaved with thrombin, purified to homogeneity, and lyophilized using standard pro-tocols. The typical yield of purified VpUcyt was ∼ 12 mg/l of Luria-Bertani (LB) culture.
NMR spectroscopy
Lyophilized CD4mut was solubilized at a concentration of 1 mM in ∼ 330 μl micelle solution (200 mM DPC-d38, 20 mM sodium phosphate, 150 mM NaCl, 0.02% (w/v) NaN 3 , 10% (v/v) 2 H 2 O, pH 6.2). Sample homogeneity was achieved by vortex mixing. The sample was transferred to a (3 × 6) mm 2 2 H 2 O-matched Shigemi S-tube (Varian Inc., Palo Alto, USA) after readjusting the pH to 6.2.
NMR spectra were recorded at 45°C on Varian Unity INOVA instruments operating at 1 H Larmor frequencies of 600 and 800 MHz, respectively, and using cryogenically cooled, 5 mm 1 H{ 13 C, 15 N} triple resonance probes. The two probes were equipped with an actively shielded three-axis pulsed field gradient (PFG) or z-axis PFG coils, respectively. Experiments for sequential resonance assignment were primarily recorded at 14.1 T, while NOESY spectra were acquired at 18.8 T.
Resonance assignment of CD4mut in DPC micelles at 45°C was based on a combination of two-(2D) and three-dimensional (3D) NMR experiments: A transverse relaxation-optimized (TROSY) [5] variant of the 1 H, 15 N-HSQC [42] , a gradient-enhanced 1 H, 13 C-HSQC [43] , and 3D HNCA [44] , HNCO [45] , HCACO [46] , CBCA(CO)NH [47] , CBCA(NH) [48] , and HBHA(CBCACO) NH [49] experiments. Additional spectra were acquired for side chain assignment: 3D H(C)CH-COSY [50] , (H)CCH-TOCSY [51] , H(C)CH-TOCSY [50] , and 2D (HB)CB(CGCD)HD and (HB)CB(CGCDCE)HE experiments [52] .
Sequential and medium-range proton-proton distances were extracted from gradient-enhanced 3D 15 N NOESY-HSQC spectra [53] acquired with a mixing time of 150 ms, and from 3D gradient-enhanced 13 C-resolved HSQC-NOESY spectra [54] recorded with a mixing time of 120 ms.
NMR data processing
NMR data were processed with NMRPipe [55] . The software package CARA was used for spectral analysis and resonance assignment [56] . NOESY spectra were analysed with RADAR, a software package that includes the modules ATNOS [57] and CANDID [58] for automated NOESY peak picking and assignment, respectively.
Deviation of observed chemical shifts of protein resonances from amino acid specific random coil shifts, often referred to as secondary shifts (Δδ), is a sensitive indicator of local secondary structure [59] . Secondary shift analysis of CD4mut in DPC micelles was based on tabulated random coil 13 C α and 1 H α shifts determined by Schwarzinger et al. using Ac-GGXGG-NH2 peptides in 8 M urea [60] . Amino acid sequence-dependent corrections of the random coil shifts were applied [61] . Fractional helicity of a protein fragment with propensity for helix formation is defined as the ratio of the mean observed secondary shift averaged over the fragment and the mean secondary shift expected for a regular helix [59, 62] . Typical average secondary shifts in a helix are 2.6 ppm for 13 
Circular dichroism (CD) spectropolarimetry
CD spectra of 45 μM CD4mut in 20 mM sodium phosphate buffer (200 mM DPC-d38, 0.02% (w/v) NaN 3 , pH 6.2) with and without 150 mM NaCl, respectively, were recorded at 30, 40, and 50°C. In addition, spectra of 50 μM CD4tmcyt were acquired in the same buffer with 150 mM NaCl and supplemented with 2 mM DTT at 30°C. Far-UV CD data were collected between 260 and 185 nm on a Jasco J-810 spectropolarimeter (Jasco, Tokyo, Japan) operating in continuous scan mode (scan speed 20 nm min − 1 ; bandwidth 1 nm; time constant 8 s; accumulation of 8 scans). A rectangular suprasil QS quartz cell with a 1 mm optical path length (Hellma, Müllheim, Germany) was used. Baseline scans of DPC solutions without protein were subtracted from the CD curves.
Quantitative analysis of CD spectra was performed using the CDPro software package [63] after converting the data to per residue differential molar absorbance units (Δɛ/n in cm − 1 M − 1 ). The software includes the three methods CONTIN/LL [64] , SELCON3 [65] , and CDSSTR [66] . All three fit the experimental CD data to a linear combination of CD spectra of proteins with known crystal structures, referred to as basis set, but use different algorithms. The basis Fig. 1 . Scheme of the polypeptide CD4mut. The 70 amino acid residue protein CD4mut contains the transmembrane and cytoplasmic domains of human CD4, comprising CD4 residues 372 through 433 (highlighted by a grey background, numbering according to mature CD4 present after loss of the signal peptide [68] ) with the five point mutations C394S, C397S, C420S, C422S, C430H, and an additional N-terminal linker of eight residues (GPLVPRGS) remaining after proteolytic cleavage of the fusion protein. Residue numbers referring to this linker are enclosed in parenthesis. The cytoplasmic region of CD4 is highly cationic at pH 6.2, charged side chains are indicated underneath the sequence. The charge state of the histidines is somewhat ambiguous (expected pKa ∼ 6.5). NMR secondary shift analysis of CD4mut in DPC micelles reveals formation of two α-helices extending most likely from M372 to V395 (transmembrane helix) and from M407 to R412 (cytoplasmic helix). set SDP48 was employed. It combines reference CD spectra of 43 soluble and 5 denatured proteins covering the wavelength range from 190 to 240 nm [63] .
Analysis of interaction between CD4mut and VpUcyt
Reconstitution of the relatively small CD4mut into POPC membranes was achieved by mixing the components in organic solvent, complete removal of the solvent, and hydration with aqueous buffer. Appropriate amounts of POPC and CD4mut were separately dissolved in a mixture of chloroform and methanol (7:3, v/v), the solutions were combined in a test tube and the solvent was blown off with a fine stream of nitrogen gas. The remaining thin film of lipid and protein was redissolved in cyclohexane, frozen in liquid nitrogen, and lyophilized. Liposomes were formed by the addition of 1 ml of buffer (20 mM sodium phosphate, 73 mM NaCl, pH 6.8) or of 1 ml VpUcyt solution in the same buffer, respectively, followed by five freeze-thaw cycles and finally sonication on ice using a Branson 250 sonifier equipped with a microtip (3 × 45 s, duty cycle 50%, output control at 4).
The obtained small unilamellar liposomes with membrane-incorporated CD4mut and bound VpUcyt were separated from the bulk of the aqueous buffer containing various concentrations of the soluble VpUcyt by centrifugation. Relative amounts of VpUcyt and CD4mut in the initial liposome dispersion as well as in the pellet and supernatant fractions obtained after centrifugation were monitored by reversed phase chromatography (RPC). In detail: following an equilibration period of 1 h, two 100 μl aliquots of each of the initial 1 ml liposome dispersions were reserved for RPC analysis. Samples were centrifuged for 1 h at 20°C and 340,000 ×g using an Optima TL-100 ultracentrifuge equipped with a TLA-100.4 rotor (Beckman Coulter). The liposome pellet and the supernatant were carefully separated. The pellet was resuspended in 0.8 ml of the original buffer and 100 μl aliquots of both the supernatant and the dispersed pellet fractions were withdrawn. The 100 μl aliquots were applied to an analytical reversed phase EC 250/4.6 Nucleosil 300-7 C 4 column (Macherey-Nagel, Düren, Germany), which was mounted on an ÄKTA purifier system (GE Healthcare) and had been equilibrated with buffer A (100% H 2 O, 0.1% (v/v) TFA). Samples were eluted with a linear gradient from 100% buffer A to 100% buffer B (80% acetonitrile, 20% H 2 O, 0.08% (v/v) TFA).
Results

Protein production
The plasmid pTKK19_CD4mut allows very efficient recombinant production of the integral membrane protein CD4mut, a cysteine substitution variant of CD4(372-433) comprising the transmembrane and cytoplasmic domains of CD4. The simple and very robust protocol for expression and purification of CD4mut in E. coli provides relatively large amounts of isotopelabeled protein that are sufficient for NMR characterization and analysis of molecular interactions of the cytoplasmic domain of CD4 with other proteins. The final yield of purified CD4mut was ∼ 8 mg/l of bacterial culture, which compares favorably to the ∼ 6 mg of CD4tmcyt per liter reported previously [38] . Notably, the yield of 15 N-and 15 N/ 13 C-labeled CD4mut produced in isotope-labeled M9 medium is not significantly lower than the protein yield in LB medium. The identity and high purity of CD4mut and of its isotope-labeled variants was confirmed by SDS-PAGE, analytical RPC, and electrospray ionization mass spectrometry.
Interaction between CD4mut and VpUcyt
The procedure used for membrane reconstitution of CD4mut relies on component mixing in organic solvent. Successful in-corporation of CD4mut into the lipid membrane vesicles was verified in initial tests without VpUcyt. A lyophilized mixture of POPC and CD4mut was dispersed in 2 H 2 O-based buffer following our standard protocol. After centrifugation the liposome fraction was floating on top of the optically clear buffer. Any aggregated CD4mut, if present, would be expected to sediment on the bottom of the test tube. Liposome float and buffer were carefully separated and analyzed by RPC. For this purpose, the entire buffer fraction, but only 1/12-th of the redispersed liposome solution was applied to the column. As expected, the majority of the lipid and CD4mut is found in the liposome float fraction. However, small CD4mut and POPC peaks accounting for less than 10% of the total amount of CD4mut and lipid, respectively, present in the initial sample were detected in the buffer fraction, too. Notably, the ratio of the integral peak intensities of POPC and CD4mut was nearly identical in both fractions. Most likely, the small amount of lipid and CD4mut detected in the buffer fraction reflects incomplete separation of the liposome float from the clear buffer fraction by decanting. Fig. 2 shows the distribution of VpUcyt between buffer and liposome pellet fractions in the absence (panels A and B) and presence (C through F) of membrane-reconstituted CD4mut. The concentration of VpUcyt was 50 μM in all samples. Indeed, virtually identical VpUcyt amounts were detected in all RPC traces of the liposome dispersion aliquots drawn prior to centrifugation (data not shown). After separation, part of VpUcyt is detected in the liposome fraction. A fully hydrated liposome pellet consists of multilamellar arrays of alternating lipid membranes and water layers and buffer filled morphological defects [67] . A typical pellet contains ∼ 50 wt.% buffer. Even in the absence of specific binding between VpUcyt and POPC an appropriate fraction of the soluble VpUcyt is expected in the pellet fraction in agreement with the small VpUcyt peak observed in Fig. 2B .
The initial sample analyzed in Fig. 2C and D contained 0.5 mg CD4mut (corresponds to 62 μM CD4mut in the sample) while Fig. 2E and F report on a sample with 2 mg (250 μM) CD4mut in the POPC liposomes. The amount of VpUcyt in the pellet clearly increases with raising CD4mut concentration in the membrane (Fig. 2D vs. F), indicating specific binding between the two proteins.
Separation of membrane-associated VpUcyt from free VpUcyt by a simple centrifugation step in combination with RPC-based quantification of VpUcyt and CD4mut in the two fractions can serve as binding assay. The amount of VpUcyt nonspecifically bound to the lipid membrane or simply trapped in the liposome pellet (Fig. 2B) is apparently much smaller than the amount of VpUcyt specifically attracted by 250 μM CD4mut in the mem-brane ( Fig. 2F) . Moreover, at 250 μM CD4mut there is more VpUcyt in the pellet fraction ( Fig. 2F ) than in the supernatant ( Fig. 2E ). If one assumes a one-to-one complex of VpUcyt and CD4mut, the dissociation constant K D of this complex should be on the order of 250 μM or lower. The lack of vectorial orientation of liposome-reconstituted CD4mut contributes to the uncertainty of this K D estimate. A significant fraction of CD4mut might not be available for VpUcyt binding, simply because their cytoplasmic domain, which contains the VpU binding motif, is pointing towards the interior of closed liposome particles.
NMR spectroscopy
The HSQC spectrum of CD4mut in DPC micelles (Fig. 3) is strikingly similar to the previously published HSQC of CD4tmcyt carrying five cysteines [38] . Pronounced 1 H and 15 N chemical shift changes are limited to the five point mutations (C394S, C397S, C420S, C422S, C430H) and to amino acids in the immediate vicinity of these sites in the sequence. 7); P(− 4); P423; P432) give rise to cis-trans isomerization of X(i -1) -P(i) peptide bonds, resulting in multiple sets of cross-peaks for amino acid stretches in the immediate vicinity of the prolines. The majority of CD4mut conformers adopt the trans form of the peptide bond connecting V(−5) and P(− 4), S422 and P423, and S431 and P432. The correlations indicated in the HSQC spectrum reflect these trans conformers. Residues in the neighborhood of the prolines exhibited additional but rather weak 1 HN-15 N correlations reflecting the weakly occupied cis form of the X(i -1) -P(i) peptide bonds. These additional cross-peaks are marked with asterisks in the spectrum. positions in the N-terminal extension are designated with negative numbers (cf. Fig. 1 ). All expected backbone correlations were observed with the single exception of H399. The absence of this 1 HN-15 N cross-peak is most likely a result of strong spectral overlap in the corresponding region. CD4mut comprises four proline residues (P(− 7); P(− 4); P423; P432) that may cause cis-trans isomerization of X(i -1) -P(i) peptide bonds. The assigned resonances in Fig. 3 belong to the highly occupied major subset of CD4mut conformers featuring trans peptide bonds between V(− 5) and P(−4), S422 and P423, as well as S431 and P432 based on the observation of NOESY cross-peaks between the δCH 2 protons of the proline and the 1 H α protons of the preceding residue [69] . Weakly populated subsets of additional peptide conformations carrying the cis form of the peptide bond prior to one of the proline residues give rise to separate low intensity 1 HN-15 N peaks of residues that are close to the prolines in the polypeptide sequence. These additional correlations are labeled by asterisks in the HSQC spectrum in Fig. 3 .
A carefully conducted initial screen of experimental conditions like buffer composition, choice of detergent, and temperature identified optimized conditions for acquisition of high quality NMR spectra that were employed in the current study. In particular, working at the elevated temperature of 45°C provided the best spectral dispersion and narrowest resonance line widths. A further increase in temperature beyond 45°C was impractical due to protein stability issues and NMR hardware limitations. The good resolution of the HSQC spectrum indicates feasibility of high resolution NMR studies on the CD4 fragments in DPC micelles at 45°C. The rotational correlation time of micelle-embedded protein depends on the mass of the entire complex, consisting of an estimated 50 to 60 DPC-d38 monomers (aggregation number of DPC in water [70] , FW = 390) and one CD4mut (FW = 7.850), which amounts to a complex of ∼ 30 kDa. Therefore, the TROSY version of the 1 H, 15 N-HSQC shown in Fig. 3 gives narrower resonances than an ordinary decoupled HSQC, however at the expense of a longer acquisition time [5] . Heavy overlap of amide resonances is observed close to 8.1 ppm, most likely due to the reduced chemical shift dispersion of amide protons in α-helices and unstructured regions. This signal degeneracy in two-dimensional spectra clearly indicates a need for 15 N/ 13 C doubly labeled protein and NMR data sets of higher dimensionality for resonance assignment and detailed NMR characterization of CD4mut and of its molecular complexes.
Nearly complete resonance assignment was accomplished for CD4mut in DPC micelles at 45°C using a standard set of multidimensional triple resonance experiments. Fig. 4 shows an HNCA-based sequential walk through the particularly challenging transmembrane domain of CD4mut. All backbone amide ( 15 N, 1 HN) and 13 
Secondary chemical shift analysis
The plot of 13 C α and 1 H α secondary chemical shifts of CD4mut in DPC micelles (Fig. 5 ) clearly reveals two continuous stretches of downfield 13 C α and concomitant upfield 1 H α shifts indicative of α-helix formation. The extension of the two helices is estimated using Δδ 13 C α and Δδ 1 H α thresholds of 1.1 and − 0.1 ppm, respectively, resulting in helical segments 372-395 and 405-412 (based on Δδ 13 C α ) or 372-396 and 407-412 Fig. 4 . Strip plots of the correlations of backbone amides of residues M372 through F393 of the transmembrane domain of CD4mut taken from a three-dimensional HNCA. Each amide is correlated with the intraresidue 13 C α chemical shift. Often an additional, less intense correlation with the 13 C α shift of the preceding residue is observed, too. The dashed line traces the connectivity pattern. Amino acid residues are specified below the strips.
(based on Δδ 1 H α ). The termini of the two helices are apparently frayed rather than well defined. As a conservative consensus of the chemical shift data we suggest a hydrophobic transmembrane helix extending from M372 to V395 and a short cytoplasmic helix from M407 to R412 (cf. Figs. 5 and 1) . The fractional helicity of these two regions is estimated from the average of the secondary shifts measured. The TM helix is characterized by ∼ 100% and ∼ 86% helicity based on the averages of the experimental Δδ 13 C α and Δδ 1 H α values, re-spectively. The cytoplasmic helix has a lower helicity of ∼ 80% (based on the mean Δδ 13 C α ) and ∼69% (based on the mean Δδ 1 H α ). Assuming that the amino acid residues located outside the two helical regions do not show any helical character (equivalent to 0% helicity), we calculated the average helicity of the 70 residue CD4mut polypeptide. Overall helicities of ∼ 43% and ∼35% are derived for CD4mut from the Δδ 13 C α and Δδ 1 H α analyses, respectively. Of course, these numbers provide only very coarse estimates and must be interpreted with caution.
Characteristic NOE pattern reveals two helices
Regular secondary structure elements give rise to typical NOE intensity pattern with sequential and medium-range proton-proton NOE interactions that reflect short protonproton distances characteristic of these structures [69] . Fig. 6 is a diagrammatic presentation of NOE connectivities of CD4mut in DPC micelles at 45°C. The data suggest the existence of two helices in CD4mut. Most likely, the transmembrane helix ranges from M372 to F392, but may extend up to R396 based on the observed H α (i)/H β (i + 3) cross-peaks correlating F392 and V395 as well as F393 and R396 and the considerable intensity of the sequential HN(i)/HN(i + 1) cross-peaks in the stretch from I391 through S397. The shorter cytoplasmic helix very likely extends from R406 to L414, but the exact limits of the helical secondary structure may vary by one or two amino acid residues on either side.
CD spectropolarimetry
The CD spectra of CD4mut and CD4tmcyt in DPC micelles are very similar (Fig. 7A ). They show local minima at ∼ 208 and ∼220 nm, indicative of a significant fraction of helical structure. Measurements in buffer containing 150 mM NaCl are confined to wavelength above 195 nm due to strong absorption of chloride ions below 195 nm. However, even in salt free buffer CD data at small wavelength were compromised by light scattering caused by the micelles. Reference CD spectra of the basis set SDP48 employed in the CDPro analysis are available from 190 to 240 nm only. Therefore, spectral analysis was restricted to the range from 195 to 240 nm. The three methods CONTIN/LL, SELCON3, and CDSSTR used for quantitative curve fitting of the CD spectra provided similar estimates of secondary structure. The following distribution of conformations was obtained for CD4mut: 39 to 43% helix, 12 to 15% βstrand, 16 to 19% turns, and between 23 and 31% unordered conformations. The fractions of secondary structure estimated in case of CD4tmcyt are very similar: 37 to 42% helix, 10 to 17% β-strand, 16 to 20% turns, and between 27 and 32% unordered conformations. CDPro analysis was repeated with a second basis set of reference spectra (SMP56, utilizing CD spectra of 43 soluble and 13 membrane proteins [71] ). Interestingly, the above estimates of secondary structure content were virtually unchanged.
Changing the temperature from 30 to 50°C caused only minor changes in the CD spectrum of CD4mut in DPC micelle solution both in the presence and absence of 150 mM NaCl in the buffer. CD spectra of CD4mut recorded at 30, 40, and 50°C with 150 mM NaCl in the micelle solution are presented in Fig. 7B . Data analysis with CDPro indicated a reduction of helical structure by no more than 4% with a concomitant increase in unordered conformations upon raising the temperature from 30 to 50°C.
Discussion
Human immune cells displaying CD4 at their surface are the primary target for infection with the human immunodeficiency virus (HIV-1). CD4 serves as the main receptor for HIV entry into the cell. The immunoglobulin-like ectodomain of CD4 is specifically targeted by the trimeric surface glycoprotein gp120 of the virus. Immediately after infection the virus initiates down-regulation of CD4 expression at the host cell surface by several independent mechanisms [72] . Binding between CD4 and gp160, the precursor of HIV-1 envelope glycoprotein, traps CD4 in the ER. Viral protein Nef enhances endocytosis of surface exposed CD4 resulting in CD4 degradation in lysosomes. Viral protein U (VpU) is implicated in degradation of newly synthesized CD4 in the ER by targeting CD4 to the proteasomal pathway via ubiquitination. Both VpU and Nef specifically interact with the C-terminal cytoplasmic domain of CD4 [26, 27] . In particular, the sequence L414-T419 in the cytoplasmic domain of CD4 is required for VpU mediated degradation of CD4 according to mutational studies [73] .
All five cysteine residues within the C-terminal stretch of amino acids 372 to 433 of human CD4 have been replaced in the CD4mut polypeptide to simplify sample handling. These five substitution mutations introduced in CD4mut are located outside the known VpU and Nef target sequences on CD4 [27, 28, 35, 73] . Cysteines 394 and 397 of CD4 are palmitolylation sites [74] , C420 and C422 participate in a zinc coordinated ternary CD4-Lck-Zn 2+ complex [37] . The substitution of C430 by a histidine was motivated by the occurrence of histidine in murine CD4 at this position. The conformation of the cytoplasmic and transmembrane domains of unbound CD4 in membrane simulating DPC micelles is largely unaffected by these conservative point mutations as demonstrated by the very similar CD spectra ( Fig. 7) and chemical shifts, apart from the mutated residues themselves, of CD4mut ( Fig. 3) and CD4tmcyt ( Fig. 6 in [38] ). The observed binding of the soluble Vpu fragment VpUcyt to membrane-reconstituted CD4mut indicates biological relevance of the CD4mut construct for at least one aspect of CD4 function and justifies the use of CD4mut in future NMR-based studies of the structure and the mode of interaction of the CD4 VpU complex.
Separation of CD4-bound and membrane-associated VpU from free VpU in the buffer by centrifugation in combination with RPC for quantitative analysis of the buffer and pellet fractions provides a simple method to estimate binding affinity between membrane-reconstituted CD4 and soluble VpU fragments. Similar approaches have been used earlier to quantify partition of small molecules between the lipid bilayer and the water phase [75, 76] or to study binding of peptides and proteins to phospholipids vesicles [77, 78] .
The conformation of CD4mut in DPC micelles was studied using analysis of secondary chemical shifts and NOE connectivity patterns in concert with CD spectroscopy. Secondary 13 C α and 1 H α chemical shifts are particularly sensitive to backbone torsion angles φ and ψ [9] . Systematic deviations of these chemical shifts from random coil specific values over a continuous stretch of amino acid residues provide a strong indication for α-helix or β-sheet structures [59] . Intense sequential HN(i)/HN(i + 1) NOEs in combination with intermediate intensity H α (i)/HN(i + 1), H α (i)/HN(i + 3) and H α (i)/H β (i + 3) NOESY cross-peaks are a hallmark of regular helices [69] . However, the exact extension of secondary structure elements is often difficult to define due to frayed ends of the structured regions. This is particularly true if a protein adopts an ensemble of structures. Both 13 C α and 1 H α chemical shifts as well as the NOE connectivity pattern of CD4mut in DPC micelles indicate formation of a long (transmembrane) and a short (cytoplasmic) helix but with slightly different length ( Figs. 5 and 6) . The secondary shifts of the residues between the two helices reveal some helical character, but the Δδ values are below the threshold for regular helices. The N-and C-termini of CD4mut appear to be unstructured, however, turns or short strands might go undetected in a secondary shift analysis. Fig. 8 shows a schematic representation of the two observed helices in the context of a detergent micelle.
Chemical shifts measured for an ensemble of conformers undergoing fast exchange represent a time-weighted average of the individual shifts. The average magnitude of the measured secondary shift allows estimates of the fraction of conformers that adopt a selected α-helix or β-sheet, respectively. Observation of just one set of chemical shifts in all NMR spectra of CD4mut is compatible with either a unique conformation or fast conformational exchange on the chemical shift time scale. The transmembrane helix occurs in all or almost all CD4mut conformers according to the averaged 13 C α and 1 H α secondary shifts, respectively. The fractional helicity of the short cytoplasmic helix is lower and amounts to 69 to 80%, indicating some conformational flexibility in this region. The NOE pattern of the cytoplasmic helix features H α (i)/HN(i + 1) connectivities that are on average comparable in intensity or even stronger than the HN(i)/HN(i + 1) peaks in contrast to the corresponding distances of 3.5 and 2.8 Å, respectively, in a regular α-helix. This observation might indicate conformational averaging be-tween helical and non-helical structures [79, 80] , in qualitative agreement with a reduced fractional helicity of the cytoplasmic helix derived from secondary shift analysis.
Fitting the CD spectrum of a protein to a linear combination of CD spectra of proteins with known structure provides a quantitative estimate of secondary structure elements in the protein under study. A CD spectrum is based on all peptide conformers present in the sample averaged over both the peptide sequence and time.
In order to compare the results of secondary shift and CD spectral analysis we estimated the overall helicity of the 70 residue CD4mut from the chemical shift data. The NMR-derived overall helicity of ∼ 35 to ∼ 43% agrees well with the CD-based estimate of ∼39 to 43% helical secondary structure. An important advantage of the more elaborate NMR analysis is the precise localization of the helical regions in the amino acid sequence, while the CD analysis has a higher sensitivity for detection of turns and short β-strands. Indeed, the CD spectrum of CD4mut in micelles indicates occurrence of a sizable fraction of residues in turns (∼ 16 to 19%) and β-strands (∼12 to 15%) in addition to the dominating helices and a large number of residues in unstructured regions.
The structure of the cytoplasmic domain of CD4 has been studied previously by NMR and CD spectroscopy using the soluble synthetic peptides CD4(403-419) [81] and CD4(396-433) [37, 82] . Willbold and Rösch identified an α-helix in aqueous solution covering the sequence Gln403 to Arg412. The average α-helical content of the 17 residue peptide was ∼25%, indicating that the helical structure was present in a subset of conformations only. Wray et al. studied the 38 residue peptide representing the entire cytoplasmic domain of CD4 in water and in trifluoroethanol (TFE) solution. In aqueous solution the polypeptide was found to be unstructured [37, 82] . Helical secondary structure was observed only in the presence of organic solvent and the helical content increases with the concentration of TFE in buffer. At 50 vol.% TFE an α-helix is observed that extends from Arg402 to Lys417 with an average fractional helicity of 62% in the central part (Gln403 to Ser415) based on 1 H α secondary chemical shift analysis [82] . The cytoplasmic helix identified in the current study is shorter (Met407 to Arg412) but has a higher fractional helicity (∼69 to 80%). Anchoring the CD4mut peptide in a membrane mimicking micelle does apparently stabilize this short helical segment, perhaps this could be a result of the amphipathic character of the cytoplasmic helix. Although our secondary shift data and the NOE connectivity pattern indicate some helix propensity for the residues flanking the cytoplasmic helix (Fig. 5 ) the observed fractional helicity in these two regions is low. Interestingly, computer-based sequence analysis predicts an αhelical conformation of the CD4 fragment Arg402 to Thr419 [83] supporting an intrinsic propensity of this sequence for helix formation. It is conceivable that the cosolvent TFE, which is known to stabilize α-helical secondary structure [84] , causes an extension of the cytoplasmic helix that does not occur in membrane anchored CD4. Investigation of the CD4mut construct in DPC micelles provides several advantages: the TM helix anchors the molecule in the micelle and places the cytoplasmic domain in the hydrated polar head group region. Importantly, the polar head Fig. 8 . Schematic representation of the transmembrane and cytoplasmic helices of CD4mut in a detergent micelle. The ribbon diagram reflects the length of the two helices derived from secondary shift analysis and the pattern of NOE-based 1 H-1 H distances. So far, no data on the relative orientation of the two helices have been obtained. However, the amphipathic character of the cytoplasmic helix suggests intimate contact with the polar head group region. The two cylinders surrounding the helices symbolize the space requirement of the amino acid side chains. of DPC is chemically identical to that of phosphatidylcholine lipids, which are abundant in membranes of eukaryotic cells.
In TFE-free aqueous solution, CD4(403-419) exhibits an α-helical secondary structure for residues 403 to 412, followed by a more extended conformation [81] . This helix ends at position 412, identical to the cytoplasmic helix in the current structure. Leucines 413 and 414 are known to be important as a "dileucine" motif necessary for internalization of transmembrane proteins such as CD4, IgG Fc receptor and CD3 γ and δ chains. Interestingly, the helix within the cytoplasmic part of CD4 is prolonged in the complex with Lck(7-35) until residue 415 and both leucines (413 and 414) are reported to be covered by the Lck part [37] . Comparison of CD4 structures in the presence and absence of Lck suggests that the presence of Lck induces elongation of the membrane-proximal helix of CD4 by another turn. This induces the side chains of leucines 413 and 414 to point towards the Lck part of the complex which results in their shielding from any dileucine-targeting machinery of the cell, and possibly also from Nef.
The sequence CD4(414-419), which is considered essential for VpU binding [26, 73] , is not part of the cytoplasmic helix observed in the current study. Nevertheless, the short helix identified here is crucial for the interaction between CD4 and VpU. Mutations of CD4 intended to provoke a distorting effect on a putative α-helical conformation encompassing the region CD4(407-411) abolished VpU-induced degradation of CD4 [85] . Notably, this sequence region closely matches the cytoplasmic helix CD4 (407-412) experimentally verified in the current study. It is conceivable that binding of VpU to CD4 causes an extension of the cytoplasmic helix. Alternatively, the length of this amphipathic helix might be sensitive to the presence of electrically charged lipid head groups in the membranes of the endoplasmatic reticulum or in the model membrane system employed. These questions will be addressed in future studies using the CD4mut construct introduced here.
